{"name":"Contineum Therapeutics","slug":"contineum-therapeutics","ticker":"","exchange":"","domain":"contineum.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":51522000,"netIncome":-59978000,"cash":276642000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2024"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPVXdnb3NWZXZMVFJXNENNZmJ0U1FDT2Q1VmdLbktvNHdiUGJyVVhGZ3BSTjctQWc1dHpwLUJ4ejYxUEwtOXdUdEdTYlA2Ul9MUUNEbUlPZi1ZbVR2a0ZNdFhQZktzRURXUTV6bG9SRzhGNEk1Vkp4bzFvNlU0d0VnZmlmUC04M09hZkxFZ3VISUZqTGRJdVVYcUF1QV9FZkQtVmFsajRnRGZYM3lRN01UVS1ldHRxWWhvTDFKUlRET2lkQUtGYXRxaHBnYW1HR3FkaXZZ?oc=5","date":"2026-03-13","type":"pipeline","source":"Business Wire","summary":"Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire","headline":"Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxOMl9xSEpkeUExbFRIYy1ZbkV0a0ZmYVBGR24tOVNVekpqQXl4UE40UWRhZ0JoLTBDNy1GT1NlYmxTVGpfZlFIcFg3WmRfSXNmaDRJQXUyXzdxdlJtc0V4Vm1HOE9lUXBsWThqMldzNy1iZUZSWGV4NUp4V25kN1c3Y3N5VkhBek9tLThqS1I5LTVscVNXU1ZjODVhUkJJMVduUlpRY3FXX002Y0RlR3pCQ2RmTzlWSkExRDdkbW5kR2FJMURUZVRld3Z2X1hyMEJHczVxRmY2ZmNoTmZVWEVFYUJUOU45azh0OHgxVGg3bTVnT1B3cXJaQkN3X0JYU2xBREo0c0R3OXJ4cS10WUt4bmRXYWtsNmU4dW9uRHBwaUc?oc=5","date":"2026-03-11","type":"pipeline","source":"The Globe and Mail","summary":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Design Therapeutics (DSGN) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail","headline":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Design Therapeutics (DSGN) and Vertex Pharmaceuticals (VRTX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxOZk81SUZJYlA2X0NNMkNrNGtSMlRmWFd5SUJBS1RtZmVkaUVWTGNpT1M0RzVfVkRTRnRrRmQ0c3htQS01akJnWGZheVVSZXhQQVBZeWI5MVNuQlJxN0plZ2Uwd1NIWEVIcnREMzNuX1l1Mm1YNGNRdmQ4cVBfaGx5SVRNbkZpLTlYVVFsNlZEeV8wdFVlQTNxQmpfZzhfY21tUlBZNU5YSktZam5mc0I5dm5fUzJmLTF1Y3BPc3lkMDhKbWdZUTZNUFd0anhZWTNrcGhGUVFFWVJCcmNfVUp1bUZPR19EQmNDY0dwZlJkLXVEOE5wVThrMg?oc=5","date":"2026-03-07","type":"deal","source":"The Globe and Mail","summary":"Stifel Nicolaus Keeps Their Buy Rating on Contineum Therapeutics, Inc. Class A (CTNM) - The Globe and Mail","headline":"Stifel Nicolaus Keeps Their Buy Rating on Contineum Therapeutics, Inc. Class A (CTNM)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNUXNfcGFEdnFZVldTM3BoRnZpOGZkekN2QWlkeU9UWTAxUi1OenJ2WkJqZDhrLXNzRFR4N1ZjdmMxcWQ4QmljSm5USXJIa3JpbmR2NDhlQndrOW1RYWp0bklnUDB1dHpWM1ZrNkF3ajZEUWYxZmRvaXZURkQwWXpudWJ6N1ItbDJHUTJvQ1REdVBmQWhOdUxFbkQxZTdfbEdTX0FHWGVoSk1Oc1FwbW9tcXhCN1IzaTVoY1pKWlV2Vi1hM0ZoVVAxNmpFOEg3ZG1kS19wTVZ1TEliYmhxUVBrTXNRUXRTSXpUSHFkeExIX0dsNG1lX25lcUtGNUJhUQ?oc=5","date":"2026-03-05","type":"earnings","source":"Business Wire","summary":"Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones - Business Wire","headline":"Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones","sentiment":"neutral"},{"date":"2026-03-05","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNdU5ILVJmaGJjWXdOZHhVdFg5WFkteGxVV3pHekRadTZEcHdSTHZFRnV4ejM5Qlc4bUVkNDNyN1dtbjlxZVA2WjV1WE1vYk5lSnVwWEI2WFhlaUpTYnVXRFYyWUJDRjk5VmRZOVhnYkdadm02blRKUURpUUJ2LUFGeEItdXJFR3JvVXc1bFZPS01NNmxUQjl6OWx0UkZJWjJTLTU0Zjk0RkM0VTNsTWdJZUpiNFowZVFkWVUtQ3Q5ZE1UaHVjUzRqVm5hb2hMSzd4ZmJVVnVmX0k2aVpubk5TZHF3?oc=5","date":"2026-03-03","type":"deal","source":"Business Wire","summary":"Contineum Therapeutics to Present at the 2026 Leerink Partners Global Healthcare Conference - Business Wire","headline":"Contineum Therapeutics to Present at the 2026 Leerink Partners Global Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOVjYtTlVvdUNlbEUyTXBUNnlLNzRnOFZrbW9oaXpTZnRUcTNXX3MzeVdMZi02NGdfb3pIQ2VybmJrcDF3QXl5NGg4TWpqQVlaMmM4QXQzYWVJUGdfMzEyWS1rUFZIeVMwalhPWUR5T3FYd1gzNlVCQnBWSXlYY00wMldCTy1nd2w5Y0tSR3puYVZHSjh1dEl6WDU5SWlVTUE?oc=5","date":"2025-11-21","type":"pipeline","source":"BioPharma Dive","summary":"A brain biotech’s top drug fails against MS - BioPharma Dive","headline":"A brain biotech’s top drug fails against MS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPSlEwbExNaUlCX1hvN1RlYmQtQjZiWEtJOUpaM040OE5YMjdiXzc5d1hQU295QlAwb1oxcU9FbExZYlYwaTRfR1phMnE2LWVROGFXRWNfS1BMWlpsQ1l5b1g1Ymk1ZXZpcW1HWVAzSHdYWDNFNVRvbVNyTXpDdmdOYWdKYlI0VndrOTcycldRVDlLTFd1dnlDRDBUdVhlZjhjNFNN?oc=5","date":"2025-11-21","type":"trial","source":"BioSpace","summary":"J&J, Contineum Fail ‘Risky’ Mid-Stage Multiple Sclerosis Trial - BioSpace","headline":"J&J, Contineum Fail ‘Risky’ Mid-Stage Multiple Sclerosis Trial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPWXdXOVZRaVVGN1BmWVMxTzk3WTV2OGhqVmlCaEk3OVRLZ0VDOXJzS1VZMWJQU1R3NVFwZTMwQi1oclJkV04ySjFEY2llOU9hazc2czZwVzc4QnZVZkVHNmVlRXd1Z29VZF85d0NXWldvUE9rQzUtdTdDRUlrd25MMldCXzVwcFZLdE9oMkZKQzR6SEdrcDJsTlZB?oc=5","date":"2025-11-21","type":"trial","source":"The Pharma Letter","summary":"Contineum stock down after MS drug fails in trial - The Pharma Letter","headline":"Contineum stock down after MS drug fails in trial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNZUphalpRSFpGWEJxZGM4YXFxTjlKeTFUY2FxWktEbVJrT1l5cWJHeGhxLXd0ZXdzaEUzRVBHMHYwdkJjTF9RUF9zSmUzQTVlRDdMVjkxYjN4U3N2c1ZyWTF2Q003ekQ1cmVLR2oxRHFUbXQzYWJNTlFXN3hxYjFKQ3ZFZHhuVXJWamdRYkVzQ1pTOFAwWE04WnBELTNzLW8?oc=5","date":"2025-11-20","type":"trial","source":"Fierce Biotech","summary":"Contineum's J&J-partnered MS drug fails to improve vision in phase 2 - Fierce Biotech","headline":"Contineum's J&J-partnered MS drug fails to improve vision in phase 2","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9fVE51SUR5YzU1c1VzWnU5ZE9JUDZOdzU2UEdHMzZpRjczeDAyV2FEOXhqTUlKZlg3ekZUNHJUdmtiMXNqTG5URmZ0dWxnQmNSWkM0?oc=5","date":"2025-11-20","type":"trial","source":"FirstWord Pharma","summary":"Contineum's shares sink after asset licensed to J&J flunks mid-stage MS study - FirstWord Pharma","headline":"Contineum's shares sink after asset licensed to J&J flunks mid-stage MS study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNbjBPbHNhTG5Ob2ZSWWFUTEM5VDdENkZsQUZfZkYwOVd1Z2NuYWpFRzBRZUlZNFYxSzN5REthU3BLTlM0SlF1R09wWlIxUU1HVWhBRkQzamdsbzRLUm83RlBtWno3LXFFVk9HV1VQOFBjSXBleDJ1MWV3ZU8wX2xDdDdJZFBfSTFDOGhpOHBPakxUZndtVW01Q0VyQUxmRlRnYkhhNWs4a1FWLXNXNGc?oc=5","date":"2025-08-06","type":"pipeline","source":"Fierce Biotech","summary":"Contineum reroutes pipeline, funneling cash from MS to lung disease as it eyes showdown with BMS - Fierce Biotech","headline":"Contineum reroutes pipeline, funneling cash from MS to lung disease as it eyes showdown with BMS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPMzRnemdOa3pKMjFBOUhYVkFPOFBNUlBVYWc4OTJHbC04eGhWbU5YQlFXOWlmc3NwX3p6UWNLT0lnVjFrc0J4aF9JTy1Qcko1dHgxUmVGa0d4NWpxOWZrYmNnU2huZFJ0NVZVMS1LT0V2ZUNCMmVVYnEtRWtiQWJFX1hNSkYtZGVaSTBhQXBlMTZZZWVoWGhWdjAtbm9XemdVN01aeU5hTGlyTlU4SWZ2dmdMX3lxMkMyU0NpVXdQbTkxdkNqY0hDWkxKTXhkTzItNFVCWmtDczE4b0VER3RCS01HX29jZw?oc=5","date":"2025-05-14","type":"earnings","source":"BioSpace","summary":"Contineum Therapeutics Reports First-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones - BioSpace","headline":"Contineum Therapeutics Reports First-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2024-12-31","revenueHistory":[{"value":0,"period":"2024-12-31"},{"value":50000000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":51522000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-59978000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":276642000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}